AI assistant
Cellebrite DI Ltd. — Regulatory Filings 2021
Nov 10, 2021
31078_ffr_2021-11-10_aa1e81c1-b517-43a0-9636-3477cda3a40e.zip
Regulatory Filings
Open in viewerOpens in your device viewer
6-K 1 ea150290-6k_cellebrite.htm REPORT OF FOREIGN PRIVATE ISSUER
Field: Rule-Page
Field: /Rule-Page
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Field: Rule-Page
Field: /Rule-Page
FORM 6-K
Field: Rule-Page
Field: /Rule-Page
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
Under the Securities Exchange Act of 1934
For the month of November 2021
Commission File Number 001-40772
Field: Rule-Page
Field: /Rule-Page
Cellebrite DI Ltd.
(Exact name of registrant as specified in its charter)
Field: Rule-Page
Field: /Rule-Page
94 Shlomo Shmelzer Road
Petah Tikva 4970602, Israel
(Address of principal executive office)
Field: Rule-Page
Field: /Rule-Page
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Field: Rule-Page
Field: /Rule-Page
Field: Page; Sequence: 1
Field: /Page
EXPLANATORY NOTE
On November 10, 2021, Cellebrite DI Ltd. (the “ Registrant ” or “ Perion ”) issued a press release titled “Cellebrite Announces Third Quarter 2021 Results.” A copy of this press release is furnished as Exhibit 99.1 herewith.
The GAAP financial statements tables contained in the press release attached to this report on Form 6-K are incorporated by reference into the Registrant’s registration statement on Form S-8 (File No. 333-260878).
Field: Page; Sequence: 2; Options: NewSection; Value: 1
Field: Sequence; Type: Arabic; Name: PageNo 1 Field: /Sequence
Field: /Page
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| /s / Dana Gerner |
|---|
| Dana Gerner |
| Chief Financial Officer |
2
Field: Rule-Page
Field: /Rule-Page